RVNC
Revance Therapeutics Inc
Price:  
3.65 
USD
Volume:  
4,122,600.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC Relative Valuation

-967.7%
Upside

As of 2025-06-22, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (31.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -967.7%.

The range of the Relative Valuation is (30.18) - (31.31) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.0x - 17.7x 17.5x
Forward P/E multiples 17.1x - 19.6x 18.4x
Fair Price (30.18) - (31.31) (31.67)
Upside -926.8% - -957.8% -967.7%
3.65 USD
Stock Price
(31.67) USD
Fair Price

RVNC Relative Valuation - Historical P/E Data

Date P/E